ADPT240719P5000
- 0.90
- -0.08-8.16%
Adaptive Biotechnologies Newsroom
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Warby Parker (WRBY) and Adaptive Biotechnologies (ADPT)
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), Veracyte (VCYT) and Nevro Corp (NVRO)
Analysts Offer Insights on Healthcare Companies: Clover Health Investments (CLOV), Cogent Biosciences (COGT) and Adaptive Biotechnologies (ADPT)
BTIG Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)
Adaptive Biotechnologies Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX) and Adaptive Biotechnologies (ADPT)
J.P. Morgan Sticks to Its Buy Rating for Adaptive Biotechnologies (ADPT)
BTIG Reaffirms Their Buy Rating on Adaptive Biotechnologies (ADPT)
Analysts' Top Healthcare Picks: RxSight (RXST), Adaptive Biotechnologies (ADPT)
Adaptive Biotechnologies Analyst Ratings
Scotiabank Keeps Their Buy Rating on Adaptive Biotechnologies (ADPT)
Adaptive Biotechnologies: Hold Rating Justified by Mixed Financial Results and Ongoing Strategic Review Uncertainty
Adaptive Biotechnologies Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Adaptive Biotechnologies (ADPT), Benitec Biopharma (BNTC)
Adaptive Biotechnologies: Hold Rating Maintained Amid Cautious 2024 Financial Outlook
BTIG Reaffirms Their Buy Rating on Adaptive Biotechnologies (ADPT)
BTIG Keeps Their Buy Rating on Adaptive Biotechnologies (ADPT)
Scotiabank Keeps Their Buy Rating on Adaptive Biotechnologies (ADPT)
Piper Sandler Maintains Overweight on Adaptive Biotechnologies, Lowers Price Target to $6
Adaptive Biotechnologies Analyst Ratings